Senior Director, Strategic Market Access Initiatives at Gilead Sciences

Foster City, California, United States

Gilead Sciences Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

  • Deep understanding of the U.S. healthcare landscape, U.S. pricing and contracting dynamics, and the Market Access organization
  • Strategic thinker with exceptional communication skills
  • Ability to represent the Vice President of Market Access in executive-level forums
  • Capable of translating complex strategies into clear, actionable insights and executive-level presentations with clear storytelling
  • Located out of Foster City, CA headquarters

Responsibilities

  • Lead short-term, high-impact initiatives with urgency and precision, serving as a catalyst for strategic transformation within Market Access
  • Develop and execute cross-functional strategies in response to evolving healthcare policies, payer dynamics, and corporate priorities, working across Market Access functions
  • Drive scenario planning and risk mitigation strategies related to pricing, reimbursement, and access
  • Serve as a central point of coordination across Market Access teams and broader corporate functions to ensure strategic alignment and timely execution
  • Support preparation for earnings calls and Quarterly Business Reviews, including development of key U.S. Market Access related messages, data synthesis, and response coordination
  • Facilitate communication and alignment across Market Access teams on urgent initiatives (including quarterly business review questions), ensuring consistent implementation and awareness
  • Represent the Vice President of Market Access in C-level meetings and strategic planning sessions
  • Translate complex strategies into digestible formats for executive audiences through written communications, presentations, and live discussions
  • Build strong relationships with Market Access leadership and cross-functional stakeholders to ensure effective communication and responsiveness to urgent matters

Skills

Market Access
Healthcare Policy
Pricing Strategies
Contracting
Patient Access
Cross-Functional Leadership
Strategic Initiatives

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI